Enhancing Antitumor Activity in Adult T-Cell Leukemia
Author Information
Author(s): Hiroki Yano, Takashi Ishida, Kazunori Imada, Tomomi Sakai, Toshihiko Ishii, Atsushi Inagaki, Shinsuke Iida, Takashi Uchiyama, Ryuzo Ueda
Primary Institution: Nagoya City University Graduate School of Medical Sciences and Kyoto University Graduate School of Medicine
Hypothesis
Can G-CSF enhance the antitumor activity of the anti-CCR4 monoclonal antibody KM2760 in a mouse model of adult T-cell leukemia?
Conclusion
G-CSF significantly enhances the antitumor activity of KM2760 in a mouse model of adult T-cell leukemia.
Supporting Evidence
- G-CSF increased granulocyte counts in SCID mice.
- KM2760 treatment led to significant tumor volume reduction compared to control.
- All mice treated with KM2760 plus G-CSF achieved complete remission.
Takeaway
This study found that a drug called G-CSF can help another drug, KM2760, work better against a type of blood cancer in mice.
Methodology
SCID mice were treated with KM2760 and/or G-CSF, and tumor volumes were measured to assess antitumor activity.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
SCID mice were used in the study.
Statistical Information
P-Value
0.0053
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website